
This video with Stacy Moulder, MD, highlights efforts to identify various subtypes and molecular targets in triple-negative breast cancer, which could lead to treatment options with already approved agents.
Your AI-Trained Oncology Knowledge Connection!
Published: February 4th 2017 | Updated: